ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
282.35
-0.93 (-0.33%)
At close: Oct 8, 2025, 4:00 PM EDT
283.69
+1.34 (0.47%)
After-hours: Oct 8, 2025, 7:34 PM EDT

ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of $41.20 billion. The enterprise value is $40.84 billion.

Market Cap41.20B
Enterprise Value 40.84B

Important Dates

The next estimated earnings date is Thursday, October 23, 2025, after market close.

Earnings Date Oct 23, 2025
Ex-Dividend Date Aug 14, 2025

Share Statistics

ResMed has 145.91 million shares outstanding. The number of shares has decreased by -0.14% in one year.

Current Share Class 145.91M
Shares Outstanding 145.91M
Shares Change (YoY) -0.14%
Shares Change (QoQ) -0.12%
Owned by Insiders (%) 0.53%
Owned by Institutions (%) 68.45%
Float 144.98M

Valuation Ratios

The trailing PE ratio is 29.69 and the forward PE ratio is 25.99. ResMed's PEG ratio is 1.89.

PE Ratio 29.69
Forward PE 25.99
PS Ratio 8.05
Forward PS 7.29
PB Ratio 6.93
P/TBV Ratio 16.77
P/FCF Ratio 24.79
P/OCF Ratio 23.52
PEG Ratio 1.89
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.95, with an EV/FCF ratio of 24.58.

EV / Earnings 29.16
EV / Sales 7.94
EV / EBITDA 21.95
EV / EBIT 24.20
EV / FCF 24.58

Financial Position

The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.14.

Current Ratio 3.44
Quick Ratio 2.16
Debt / Equity 0.14
Debt / EBITDA 0.45
Debt / FCF 0.51
Interest Coverage 2,884.43

Financial Efficiency

Return on equity (ROE) is 25.86% and return on invested capital (ROIC) is 16.80%.

Return on Equity (ROE) 25.86%
Return on Assets (ROA) 14.02%
Return on Invested Capital (ROIC) 16.80%
Return on Capital Employed (ROCE) 23.58%
Revenue Per Employee $515,664
Profits Per Employee $140,353
Employee Count9,980
Asset Turnover 0.68
Inventory Turnover 2.09

Taxes

In the past 12 months, ResMed has paid $276.84 million in taxes.

Income Tax 276.84M
Effective Tax Rate 16.50%

Stock Price Statistics

The stock price has increased by +21.55% in the last 52 weeks. The beta is 0.83, so ResMed's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change +21.55%
50-Day Moving Average 278.56
200-Day Moving Average 249.05
Relative Strength Index (RSI) 59.41
Average Volume (20 Days) 895,509

Short Selling Information

The latest short interest is 8.65 million, so 5.93% of the outstanding shares have been sold short.

Short Interest 8.65M
Short Previous Month 8.94M
Short % of Shares Out 5.93%
Short % of Float 5.97%
Short Ratio (days to cover) 8.77

Income Statement

In the last 12 months, ResMed had revenue of $5.15 billion and earned $1.40 billion in profits. Earnings per share was $9.51.

Revenue5.15B
Gross Profit 3.09B
Operating Income 1.69B
Pretax Income 1.68B
Net Income 1.40B
EBITDA 1.86B
EBIT 1.69B
Earnings Per Share (EPS) $9.51
Full Income Statement

Balance Sheet

The company has $1.21 billion in cash and $851.81 million in debt, giving a net cash position of $357.64 million or $2.45 per share.

Cash & Cash Equivalents 1.21B
Total Debt 851.81M
Net Cash 357.64M
Net Cash Per Share $2.45
Equity (Book Value) 5.97B
Book Value Per Share 40.77
Working Capital 2.49B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.75 billion and capital expenditures -$89.87 million, giving a free cash flow of $1.66 billion.

Operating Cash Flow 1.75B
Capital Expenditures -89.87M
Free Cash Flow 1.66B
FCF Per Share $11.39
Full Cash Flow Statement

Margins

Gross margin is 59.99%, with operating and profit margins of 32.79% and 27.22%.

Gross Margin 59.99%
Operating Margin 32.79%
Pretax Margin 32.60%
Profit Margin 27.22%
EBITDA Margin 36.15%
EBIT Margin 32.79%
FCF Margin 32.29%

Dividends & Yields

This stock pays an annual dividend of $2.40, which amounts to a dividend yield of 0.85%.

Dividend Per Share $2.40
Dividend Yield 0.85%
Dividend Growth (YoY) 11.17%
Years of Dividend Growth 13
Payout Ratio 23.03%
Buyback Yield 0.14%
Shareholder Yield 0.99%
Earnings Yield 3.40%
FCF Yield 4.03%
Dividend Details

Analyst Forecast

The average price target for ResMed is $288.89, which is 2.32% higher than the current price. The consensus rating is "Buy".

Price Target $288.89
Price Target Difference 2.32%
Analyst Consensus Buy
Analyst Count 11
Revenue Growth Forecast (5Y) 8.30%
EPS Growth Forecast (5Y) 10.48%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 31, 2010. It was a forward split with a ratio of 2:1.

Last Split Date Aug 31, 2010
Split Type Forward
Split Ratio 2:1

Scores

ResMed has an Altman Z-Score of 12.06 and a Piotroski F-Score of 7.

Altman Z-Score 12.06
Piotroski F-Score 7